SciSparc Announces Positive Topline Results For Proprietary Pain Management Compound In Pre-Clinical Study
Cannabis Law Report
AUGUST 2, 2021
Study Results Indicate SCI-160 Has A Significant Analgesic Effect on Acute and Chronic Pain. Key findings from the pre-clinical trial are as follows: SCI-160 significantly alleviates pain up to 6 hours after injection as compared with vehicle-treated animals. TEL AVIV, Israel , Aug.
Let's personalize your content